Microbiome Research Solutions


Microbiome Research Solutions

Microbiome Research Solutions

The gut microbiota is composed of thousands of different kinds of bacteria, archaea, fungus, and viruses, that produce a considerable number of compounds playing key roles in the intestine microecology and host homeostasis.

gutfloraomicsInvestigators from all over the world have done a lot of delicate work to unravel the importance of the symbiosis of gut flora, and find that gut microorganisms are potential targets of many chronic diseases. The gut flora affects the health of the host throughout the whole lifespan at a full range of aspects, including crosstalk with host immune systems, helping with food digestion and nutrient metabolism, accelerating the pathogenic progress of all kinds of chronic illnesses, as well as triggering the burst of some acute infections. Microbiome research has gained more and more attention both by academic and industrial organizations, and their results and findings have greatly speeded up the development of this novel area. Gut microbial community and its related biomolecules are promising targets in therapeutic and diagnostic fields, a better understanding of this unseen "organ" can benefit the administration of our body and health, and monitoring of gut microbes is a pharma innovation direction.

Creative Proteomics has been focused our work on gut microbiome for years, aiming to provide the best services for our academic and industrial customers to achieve their success. Creative Proteomics serves and supports our global customers with the most comprehensive solutions in gut microbiome studies. You may gain a better understanding of your research from our solutions below. Don't hesitate to contact us if you need any of our assistance.

Gut Microbiome and Host Homeostasis 

Gut Microbiota and Host Age Research
 Gut Microbiota and Host Diet Research
 Gut Microbiota and Immune System
Gut Microbiome and Diseases 
 Gut Microbiota and Gastrointestinal (GI) Diseases
  Ulcerative Colitis
  C. Difficile Infection (CDI)
  Recurrent Clostridium Difficile Infection (RCDI).
  Crohn's Disease
  Chronic Constipation
  Inflammatory Bowel Disease (IBD)
  Irritable Bowel Syndrome (IBS)
  Acute Diarrhea
  Functional Bowel Disorders (FBD)
  Celiac Disease
  Other Gastrointestinal Disorders
 Gut Microbiota and Metabolic Disorders
  Type II Diabetes
  Adipose Tissue Inflammation
  Alcoholic Liver Disease (ALD)
  Alcoholic Steatohepatitis (ASH)
  Nonalcoholic Fatty Liver Disease (NAFLD)
  Nonalcoholic Steatohepatitis (NASH)
  Cardiovascular Diseases (CVD)
  Other Metabolic Disorders
 Gut Microbiota and Autoimmune Disorders
  Hashimoto's Thyroiditis
  Multiple Sclerosis
  Systemic Sclerosis
  Sjögren's Syndrome
  Systemic Lupus Erythematosus (SLE)
  Antiphospholipid Syndrome (APS)
  Rheumatoid Arthritis
  Periodontal Diseases
  Allergic Conditions
  Atopic Dermatitis (AD)
  Primary Biliary Cholangitis
  Autoimmune Hepatitis
  Autoimmune Addison's Disease
  Other Autoimmune Disorders
 Gut Microbiota and Mental Disorders
  Bipolar Disorders
  Parkinson's Disease
  Chronic Fatigue Syndrome
  Other Neurological Disorders
 Gut Microbiota and Cancers
  Colorectal Cancer
  Liver Cancer 
  Breast Cancer 
  Gastric Cancer 
  Pancreatic Cancer
  Other Cancers 
Gut Microbiota in Therapeutic and Diagnostic Research 
 Bacterial Macromolecules as Therapeutic Targets 
 Fecal Microbial Transplant (FMT) Research 
 Microbial-Derived Biomarkers Discovery 
 Microbial Fingerprints Research 

*For Research Use Only. Not for use in diagnostic procedures.

Microbiome Service
5%-20% discount

Expires: Nov.15 — Dec.5, 2021

Online Inquiry

Verification Code